8:01 News Roundup: Official Response to Sealed Drug Records; Johnson & Johnson Talc Cancer Case Results in $15 Billion Yuan Payout; Yu Minhong Names Successor for New Oriental
Analysis
This article is a news roundup from 36Kr, a Chinese tech and business news platform. It covers several unrelated topics, including a response from the National People's Congress Standing Committee regarding the sealing of drug records, a significant payout in a Johnson & Johnson talc cancer case, and the naming of a successor at New Oriental. The article provides a brief overview of each topic, highlighting key details and developments. The inclusion of diverse news items makes it a comprehensive snapshot of current events in China and related international matters.
Key Takeaways
- •China's legislature is addressing concerns about the sealing of drug records and ensuring equal treatment under the law.
- •Johnson & Johnson faces a significant financial penalty in a cancer case related to its talc products.
- •New Oriental is preparing for a leadership transition with Yu Minhong selecting a successor.
“The purpose of implementing the system of sealing records of administrative violations of public security is to carry out necessary control and standardization of information on administrative violations of public security, and to reduce and avoid the situation of 'being punished once and restricted for life'.”